Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025)
Ascentage Pharma Group International (AAPG) posted quarterly Treasury Shares of $417479.1 for Q4 2025, up 37384.91% year-over-year from N/an in Q4 2024, and up 37384.91% quarter-over-quarter from $1113.7 in Q4 2024.
Analysis
Ascentage Pharma Group International (AAPG) Treasury Shares (2023 - 2025) Analysis & Trends
Ascentage Pharma Group International's Treasury Shares history runs 3 years deep, the most recent figure standing at $417479.1 for Q4 2025.
- In Q4 2025, Treasury Shares rose 37384.91% year-over-year to $417479.1; the TTM figure through Dec 2025 stood at $417479.1 (up 37384.91% YoY), while the FY2025 annual figure was $423000.0, up 42200.0% from the prior year.
- Treasury Shares for Q4 2025 stood at $417479.1, up from $1113.7 in the prior quarter.
- The five-year high for Treasury Shares was $3.0 million in Q4 2023, with the low at $1113.7 in Q4 2024.
- The 3-year median for Treasury Shares is $417479.1 (2025), against an average of $1.1 million.
- The sharpest annual moves came in 2024 and 2025: Treasury Shares plunged 99.96% in 2024, then soared 37384.91% in 2025.
- Ascentage Pharma Group International's Treasury Shares stood at $3.0 million in 2023, then slumped by 99.96% to $1113.7 in 2024, then jumped by 37384.91% to $417479.1 in 2025.
- Business Quant data shows AAPG's Treasury Shares at $417479.1 in Q4 2025, $1113.7 in Q4 2024, and $3.0 million in Q4 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | - |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | 2.72 Mn |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Ascentage Pharma Group International | 1.57 Bn | 1.29 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -417,479.09 |
| Dec 31, 2025 | -417,479.09 |
| Dec 31, 2024 | -1,113.73 |
| Dec 31, 2024 | -1,113.73 |
| Dec 31, 2023 | -2.97 Mn |
| Dec 31, 2023 | -2.97 Mn |